Cite
HARVARD Citation
Ocran-Appiah, J. et al. (2021). Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients. Vaccine. 39 (1), pp. 6-10. [Online].